Search Results - "Parta, Mark"

Febrile neutropenia management and outcomes in hematopoietic cell transplantation for chronic granulomatous disease.

Authors: Parta, Mark Cuellar‐Rodriguez, Jennifer Gea‐Banacloche, Juan et al.

Source: Transplant Infectious Disease. Apr2022, Vol. 24 Issue 2, p1-8. 8p.

Donor source and post‐transplantation cyclophosphamide influence outcome in allogeneic stem cell transplantation for GATA2 deficiency.

Authors: Nichols‐Vinueza, Diana X. Parta, Mark Shah, Nirali N. et al.

Source: British Journal of Haematology. Jan2022, Vol. 196 Issue 1, p169-178. 10p.

Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease.

Authors: Parta, Mark Hilligoss, Dianne Kelly, Corin et al.

Source: Journal of Clinical Immunology. May2020, Vol. 40 Issue 4, p619-624. 6p.

1689. Active, Invasive Fungal Infection, and Hematopoietic Cell Transplantation (HCT) in Chronic Granulomatous Disease (CGD): Presentation, Procedure, and Outcomes.

Authors: Parta, Mark Zerbe, Christa Holland, Steven M et al.

Source: Open Forum Infectious Diseases. 2019 Supplement, Vol. 6, pS618-S619. 2p.

Allogeneic Hematopoietic Stem Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen.

Authors: Parta, Mark Shah, Nirali N. Baird, Kristin et al.

Source: Biology of Blood & Marrow Transplantation. Jun2018, Vol. 24 Issue 6, p1250-1259. 10p.

Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial.

Authors: Parta, Mark Kelly, Corin Kwatemaa, Nana et al.

Source: Journal of Clinical Immunology. Aug2017, Vol. 37 Issue 6, p548-558. 11p.

Resolution of Multifocal Epstein-Barr Virus-Related Smooth Muscle Tumor in a Patient with GATA2 Deficiency Following Hematopoietic Stem Cell Transplantation.

Authors: Parta, Mark Cuellar-Rodriguez, Jennifer Freeman, Alexandra et al.

Source: Journal of Clinical Immunology. Jan2017, Vol. 37 Issue 1, p61-66. 6p.

Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in a Patient with Chronic Granulomatous Disease and Active Infection: A First Report.

Authors: Parta, Mark Hilligoss, Dianne Kelly, Corin et al.

Source: Journal of Clinical Immunology. Oct2015, Vol. 35 Issue 7, p675-680. 6p.

IRIS iQ200 workstation as a screen for performing urine culture

Authors: Parta, Mark Hudson, Bernita Y. Le, Thao P. et al.

Source: Diagnostic Microbiology & Infectious Disease. Jan2013, Vol. 75 Issue 1, p5-8. 4p.

GATA2 Deficiency: Early identification for improved clinical outcomes.

Authors: Cole, Kristen Avila, Daniele N. Parta, Mark et al.

Source: Clinical Journal of Oncology Nursing. Aug2019, Vol. 23 Issue 4, p417-422. 6p. 1 Diagram.

Pre- and peri-hematopoietic cell transplant management of disseminated non-Helicobacter pylori Helicobacter infection in X-linked agammaglobulinemia: Case series and literature review.

Authors: Lee, Rachel Arnold, Danielle E. Parta, Mark et al.

Source: Clinical Immunology. Apr2026, Vol. 284, pN.PAG-N.PAG. 1p.

Invasive and Allergic Complications Due to Aspergillus fumigatus in Allogeneic Hematopoietic Cell Transplantation (HCT) Primary Immunodeficiency (PID) Patients.

Authors: Parta, Mark Dimitrova, Dimana Freeman, Alexandra F. et al.

Source: Biology of Blood & Marrow Transplantation. 2019 Supplement, Vol. 25 Issue 3, pS356-S356. 1p.

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for High Risk Chronic Granulomatous Disease (CGD) Patients.

Authors: Kang, Elizabeth M. Parta, Mark Hilligoss, Dianne et al.

Source: Biology of Blood & Marrow Transplantation. Mar2016 Supplement, Vol. 22, pS327-S328. 1p.

Benefits and Costs of Rapid Drug Susceptibility in Staphylococcus aureus Bacteremia.

Authors: Parta, Mark Musher, Daniel M.

Source: Clinical Infectious Diseases. Apr2011, Vol. 52 Issue 8, p1079-1079. 1p.

Expedited Treatment of Sex Partners.

Authors: Parta, Mark J.

Source: New England Journal of Medicine. 5/12/2005, Vol. 352 Issue 19, p2026-2027. 1p.

Multidrug Resistant Pseudomonas aeruginosa Causing Prosthetic Valve Endocarditis: A Genetic-Based Chronicle of Evolving Antibiotic Resistance.

Authors: Domitrovic, T. Nicholas Hujer, Andrea M. Perez, Federico et al.

Source: Open Forum Infectious Diseases. Fall2016, Vol. 3 Issue 4, p1-6. 6p.

Hematopoietic Stem Cell Transplantation in Late-onset X-linked Chronic Granulomatous Disease in a Female Carrier.

Authors: Trevisan, Matteo Kang, Elizabeth M. CGD Consortium et al.

Source: Journal of Clinical Immunology. Oct2022, Vol. 42 Issue 7, p1396-1399. 4p.

Pulmonary Manifestations of GATA2 Deficiency.

Authors: Marciano, Beatriz E. Olivier, Kenneth N. Folio, Les R. et al.

Source: CHEST. Oct2021, Vol. 160 Issue 4, p1350-1359. 10p.

Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases.

Authors: Dimitrova, Dimana Gea-Banacloche, Juan Steinberg, Seth M. et al.

Source: Biology of Blood & Marrow Transplantation. Jan2020, Vol. 26 Issue 1, p94-106. 13p.

Donor-derived MDS/AML in families with germline GATA2 mutation.

Authors: Galera, Pallavi Hsu, Amy P. Weixin Wang et al.

Source: Blood. 11/1/2018, Vol. 132 Issue 18, p1994-1998. 5p.